Correlation Between Pfizer and Edoc Acquisition

Can any of the company-specific risk be diversified away by investing in both Pfizer and Edoc Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Edoc Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and Edoc Acquisition Corp, you can compare the effects of market volatilities on Pfizer and Edoc Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Edoc Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Edoc Acquisition.

Diversification Opportunities for Pfizer and Edoc Acquisition

0.0

Correlation Coefficient

Pfizer  Edoc Acquisition

Pay attention - limited upside

The 3 months correlation between Pfizer and Edoc is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Edoc Acquisition Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edoc Acquisition Corp and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Edoc Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edoc Acquisition Corp has no effect on the direction of Pfizer i.e., Pfizer and Edoc Acquisition go up and down completely randomly.

Pair Corralation between Pfizer and Edoc Acquisition

If you would invest (100.00) in Edoc Acquisition Corp on December 27, 2024 and sell it today you would earn a total of  100.00  from holding Edoc Acquisition Corp or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Pfizer Inc  vs.  Edoc Acquisition Corp

Pfizer Inc

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Edoc Acquisition Corp

Risk-Adjusted Performance

Very Weak

Over the last 90 days Edoc Acquisition Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Edoc Acquisition is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Pfizer and Edoc Acquisition

The main advantage of trading using opposite Pfizer and Edoc Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Edoc Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edoc Acquisition will offset losses from the drop in Edoc Acquisition's long position.

The idea behind Pfizer Inc and Edoc Acquisition Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.